S100A1: A calcium-modulating inotropic prototype for future clinical heart failure therapy
Publication
, Journal Article
Most, P; Koch, WJ
Published in: Future Cardiology
January 1, 2007
Duke Scholars
Published In
Future Cardiology
DOI
EISSN
1744-8298
ISSN
1479-6678
Publication Date
January 1, 2007
Volume
3
Issue
1
Start / End Page
5 / 11
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Most, P., & Koch, W. J. (2007). S100A1: A calcium-modulating inotropic prototype for future clinical heart failure therapy. Future Cardiology, 3(1), 5–11. https://doi.org/10.2217/14796678.3.1.5
Most, P., and W. J. Koch. “S100A1: A calcium-modulating inotropic prototype for future clinical heart failure therapy.” Future Cardiology 3, no. 1 (January 1, 2007): 5–11. https://doi.org/10.2217/14796678.3.1.5.
Most P, Koch WJ. S100A1: A calcium-modulating inotropic prototype for future clinical heart failure therapy. Future Cardiology. 2007 Jan 1;3(1):5–11.
Most, P., and W. J. Koch. “S100A1: A calcium-modulating inotropic prototype for future clinical heart failure therapy.” Future Cardiology, vol. 3, no. 1, Jan. 2007, pp. 5–11. Scopus, doi:10.2217/14796678.3.1.5.
Most P, Koch WJ. S100A1: A calcium-modulating inotropic prototype for future clinical heart failure therapy. Future Cardiology. 2007 Jan 1;3(1):5–11.
Published In
Future Cardiology
DOI
EISSN
1744-8298
ISSN
1479-6678
Publication Date
January 1, 2007
Volume
3
Issue
1
Start / End Page
5 / 11
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology